Interaction between time to treatment and reperfusion therapy in patients with acute ischemic stroke

Journal of NeuroInterventional Surgery

Volumn 5, Issue SUPPL.1, 2013, Pages

  Lansberg, Maarten G ^a   Dabus, Guilherme ^b  

^a STANFORD UNIVERSITY   (United States)

^b BAPTIST CARDIAC AND VASCULAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ARTICLE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); ENDOVASCULAR SURGERY; FIBRINOLYTIC THERAPY; HUMAN; MEDICAL PROCEDURES; NUMBERS NEEDED TO TREAT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECANALIZATION; REPERFUSION THERAPY; TIME TO TREATMENT;

BRAIN ISCHEMIA; ENDOVASCULAR PROCEDURES; HUMANS; REPERFUSION; STROKE; THROMBOLYTIC THERAPY; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 84878396942     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2013-010728     Document Type: Article

References (37)

1. Saver JL. Time is brain - quantified. Stroke 2006;37:263-6. (Pubitemid 43732089)
2. Harbison J, Hossain O, Jenkinson D, et al. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke 2003;34:71-6. (Pubitemid 36070803)
3. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981;12:723-5. (Pubitemid 12227362)
4. Heiss WD, Graf R, Wienhard K, et al. Dynamic penumbra demonstrated by sequential multitracer PET after middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab 1994;14:892-902. (Pubitemid 24332933)
5. Heiss WD. Flow thresholds of functional and morphological damage of brain tissue. Stroke 1983;14:329-31. (Pubitemid 13100308)
6. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
7. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25.
8. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-51. (Pubitemid 28470336)
9. Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. JAMA 1999;282:2019-26.
10. Hacke W, Donnan G, Fieschi C, et al. ATLANTIS Trials Investigators, ECASS Trials Investigators, NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-74.
11. Lansberg MG, Schrooten M, Bluhmki E, et al. Treatment time-speci fic number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin scale. Stroke 2009;40:2079-84.
12. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
13. Ciccone A, Valvassori L, Nichelatti M, et al. For the SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368:904-13.
14. Broderick JP, Palesch YY, Demchuk AM, et al. For the Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368:893-903.
15. Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380:1241-9.
16. Khatri P, Abruzzo T, Yeatts SD, et al. Investigators IIaI. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066-72.
17. Sun CH, Nogueira RG, Glenn BA, et al. "Picture to puncture": a novel time metric to enhance outcomes in patients transferred for endovascular reperfusion in acute ischemic stroke. Circulation 2013;127:1139-48.
18. Gupta R, Horev A, Nguyen T, et al. Higher volume endovascular stroke centers have faster times to treatment, higher reperfusion rates and higher rates of good clinical outcomes. J Neurointerv Surg 2012 Published Online First: 13 May 2012. doi:10.1136/neurintsurg-2011-010245
19. Yoo AJ, Chaudhry ZA, Leslie-Mazwi TM, et al. Endovascular treatment of acute ischemic stroke: current indications. Tech Vasc Interv Radiol 2012;15:33-40.
20. Lees KR, Bluhmki E, von Kummer R, et al. ECASS ATL, NINDS and EPITHET rt-PA Study Group. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695-703.
21. Nogueira RG, Smith WS, Sung G, et al. Committee MaMMW. Effect of time to reperfusion on clinical outcome of anterior circulation strokes treated with thrombectomy: pooled analysis of the Merci and Multi Merci trials. Stroke 2011;42:3144-9.
22. Wechsler LR, Roberts R, Furlan AJ, et al. Factors influencing outcome and treatment effect in PROACT II. Stroke 2003;34:1224-9. (Pubitemid 36547518)
23. Zaro-Weber O, Moeller-Hartmann W, Heiss WD, et al. A simple positron emission tomography-based calibration for perfusion-weighted magnetic resonance maps to optimize penumbral flow detection in acute stroke. Stroke 2010;41:1939-45.
24. Ebinger M, De Silva DA, Christensen S, et al. Imaging the penumbra-strategies to detect tissue at risk after ischemic stroke. J Clin Neurosci 2009;16:178-87.
25. Yoo AJ, Pulli B, Gonzalez RG. Imaging-based treatment selection for intravenous and intra-arterial stroke therapies: a comprehensive review. Expert Rev Cardiovasc Ther 2011;9:857-76.
26. Albers GW, Thijs VN, Wechsler L, et al. for the DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Ann Neurol 2006;60:508-17. (Pubitemid 44871793)
27. Thomalla G, Schwark C, Sobesky J, et al. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke 2006;37:852-8. (Pubitemid 43731921)
28. Hsia A, Kidwell C. Developments in neuroimaging for acute ischemic stroke: diagnostic and clinical trial applications. Curr Atheroscler Rep 2008;10:339-46.
29. Kakuda W, Lansberg MG, Thijs VN, et al. Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. J Cereb Blood Flow Metab 2008;28:887-91. (Pubitemid 351589640)
30. Lansberg MG, Thijs V, Bammer R, et al. Clinical and MRI-based risk factors for symptomatic intracerebral hemorrhage following treatment with tissue plasminogen activator. Stroke 2006;37:654.
31. Lee TY, Murphy BD, Aviv RI, et al. Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: a systematic review. Stroke 2006;37:2201; author reply 2203.
32. Murphy BD, Fox AJ, Lee DH, et al. White matter thresholds for ischemic penumbra and infarct core in patients with acute stroke: CT perfusion study. Radiology 2008;247:818-25.
33. Schaefer PW, Barak ER, Kamalian S, et al. Quantitative assessment of core/penumbra mismatch in acute stroke: CT and MR perfusion imaging are strongly correlated when sufficient brain volume is imaged. Stroke 2008;39:2986-92.
34. Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299-309.
35. Lansberg MG, Lee J, Christensen S, et al. Rapid automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Stroke 2011;42:1608-14.
36. Lansberg MG, Straka M, Kemp S, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 2012;11:860-7.
37. Kidwell CS, Jahan R, Gornbein J, et al. the MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013 Feb 8.